A Cohort Study on the Pathogen Spectrum of Liver Transplant Recipients Complicated With Infection

Launched by ZHEJIANG UNIVERSITY · Feb 19, 2024

Keywords

ClinConnect Summary

This clinical trial is looking to understand infections that can occur after a liver transplant. It aims to identify the types of germs (or pathogens) that commonly cause infections in patients who have received a liver transplant. The study also wants to explore how the immune system's strength relates to these infections and hopes to create an early warning system to help detect infections sooner. This could lead to better treatment options, ultimately reducing the risks of serious health problems after a transplant.

To be part of this study, participants should be between 18 and 70 years old, agree to join the study by signing a consent form, and have no serious health issues or complications during their recovery from surgery. They must also have undergone a liver transplant within the last 24 hours. If someone does join, they can expect to help researchers learn more about infections that can affect liver transplant recipients, which could help improve care for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Agree to participate in this study and sign the informed consent form;
• • 2. Be of any gender and aged 18-70 years old;
• • 3. No life-threatening underlying diseases and complications during the perioperative period.
• • 4. Undergo liver transplantation within 24 hours.
• Exclusion Criteria:
• • 1.Patients deemed unsuitable by the investigator to participate in the study.